Published in Environ Health Perspect on June 01, 1990
hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect (1994) 0.99
Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction. Toxicol Sci (2013) 0.99
Human physiologic factors in respiratory uptake of 1,3-butadiene. Environ Health Perspect (2001) 0.81
A brief survey of butadiene health effects: a role for metabolic differences. Environ Health Perspect (1993) 0.76
Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses. Environ Health Perspect (1993) 0.75
Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J (1987) 2.33
Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science (1985) 2.09
Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds. Mutat Res (1985) 1.08
Species differences in the disposition of inhaled butadiene. Toxicol Appl Pharmacol (1986) 1.04
Trace composition of human respiratory gas. Arch Environ Health (1975) 0.97
Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice. Environ Health Perspect (1990) 0.97
The fate of isoprene inhaled by rats: comparison to butadiene. Toxicol Appl Pharmacol (1987) 0.94
Species differences in the distribution of inhaled butadiene in tissues. Am Ind Hyg Assoc J (1987) 0.92
Pharmacokinetics of isoprene in mice and rats. Toxicol Lett (1987) 0.92
Metabolism of 1,3-butadiene by lung and liver microsomes of rats and mice repeatedly exposed by inhalation to 1,3-butadiene. Toxicol Lett (1988) 0.83
Characterization of hemoglobin adduct formation in mice and rats after administration of [14C]butadiene or [14C]isoprene. Toxicol Appl Pharmacol (1989) 0.81
A method for the continuous measurement of respiration and vapor uptake in rats. Am Ind Hyg Assoc J (1987) 0.80
Cytogenetic and other biological effects of 239PuO2 inhaled by the rhesus monkey. Radiat Res (1980) 0.80
The role of macrophages in particle translocation from lungs to lymph nodes. Science (1985) 2.52
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology (1990) 1.72
Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med (1996) 1.69
Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environ Health Perspect (1999) 1.66
Diesel exhaust is a pulmonary carcinogen in rats exposed chronically by inhalation. Fundam Appl Toxicol (1987) 1.65
Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol (1995) 1.60
Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. Eur J Pharmacol (1995) 1.54
PCBs are a health risk for humans and wildlife. Science (2000) 1.51
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol (2000) 1.46
Methods to evaluate the effects of toxic materials deposited in the lung on immunity in lung-associated lymph nodes. Drug Chem Toxicol (1979) 1.37
Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. Toxicol Appl Pharmacol (1987) 1.34
Effects of D2O on the association-dissociation equilibrium in subunit proteins. J Biol Chem (1970) 1.34
Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev Dyn (1995) 1.30
Functional organization of the Bel-1 trans activator of human foamy virus. J Virol (1993) 1.27
Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol Appl Pharmacol (1988) 1.27
Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect (1995) 1.27
Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol (1997) 1.26
Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J (1990) 1.24
The role of structure in the disposition of halogenated aromatic xenobiotics. Environ Health Perspect (1985) 1.23
Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging (2002) 1.21
Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol (1995) 1.20
Mouse strains for chemical carcinogenicity studies: overview of a workshop. Fundam Appl Toxicol (1988) 1.19
Immune responses after localized lung immunization in the dog. Am Rev Respir Dis (1980) 1.19
Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis (1992) 1.16
The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ Health Perspect (1989) 1.15
Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging (1999) 1.13
Retinoic acid-induced alterations in the expression of growth factors in embryonic mouse palatal shelves. Teratology (1990) 1.13
The use of biological markers in toxicology. Crit Rev Toxicol (1989) 1.12
Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene (1997) 1.12
Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis (1992) 1.11
A mixture of dioxins, furans, and non-ortho PCBs based upon consensus toxic equivalency factors produces dioxin-like reproductive effects. Toxicol Sci (2003) 1.11
Experimental production of gastric ulcers in swine by histamine in mineral oil-beeswax. Am J Vet Res (1966) 1.10
Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol Appl Pharmacol (1989) 1.09
Experimental production of gastric ulcers in swine by reserpine. Am J Vet Res (1966) 1.08
A physiological model for simulation of benzene metabolism by rats and mice. Toxicol Appl Pharmacol (1989) 1.08
Migration of neutrophils from lung to tracheobronchial lymph node. J Leukoc Biol (1987) 1.07
Muconic acid determinations in urine as a biological exposure index for workers occupationally exposed to benzene. Am Ind Hyg Assoc J (1991) 1.07
Oxidative damage increases with age in a canine model of human brain aging. J Neurochem (2002) 1.07
Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc Natl Acad Sci U S A (1976) 1.06
New approaches for the evaluation of pulmonary toxicity: bronchoalveolar lavage fluid analysis. Fundam Appl Toxicol (1985) 1.06
A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. Anal Biochem (1988) 1.06
Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect (1984) 1.06
Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging (1999) 1.06
S-phenylcysteine formation in hemoglobin as a biological exposure index to benzene. Arch Toxicol (1992) 1.05
Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol (1998) 1.05
An epidemiologic study of early biologic effects of benzene in Chinese workers. Environ Health Perspect (1996) 1.05
Early damage indicators in the the lung I. Lactate dehydrogenase activity in the airways. Toxicol Appl Pharmacol (1978) 1.05
Recruitment of antibody-forming cells in the lung after local immunization is nonspecific. Am Rev Respir Dis (1982) 1.05
Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health (1981) 1.05
Toxicity of gallium oxide particles following a 4-week inhalation exposure. J Appl Toxicol (1988) 1.05
Species differences in the disposition of inhaled butadiene. Toxicol Appl Pharmacol (1986) 1.04
Dose-response relationships for polyhalogenated dioxins and dibenzofurans following subchronic treatment in mice. I. CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin. Toxicol Appl Pharmacol (1997) 1.04
Lung tissue responses and sites of particle retention differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fundam Appl Toxicol (1997) 1.04
Age-related changes in the prostate and testes of the beagle dog. Vet Pathol (1990) 1.03
Role of CYP1A2 in hepatic sequestration of dioxin: studies using CYP1A2 knock-out mice. Biochem Biophys Res Commun (1997) 1.03
Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls. Toxicol Appl Pharmacol (2000) 1.03
Metabolism of 1,3-butadiene: species differences. Toxicology (1996) 1.02
Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol (2000) 1.02
Dose-response relationships for disposition and hepatic sequestration of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls following subchronic treatment in mice. Toxicol Sci (1998) 1.02
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam Appl Toxicol (1996) 1.02
Distribution and excretion of 2,3,6,2',3',6'- and 2,4,5,2',4',5'-hexachlorobiphenyl in senescent rats. Toxicol Appl Pharmacol (1983) 1.01
Regional immunologic responses following localized deposition of antigen in the lung. Exp Lung Res (1980) 1.01
Alterations in particle accumulation and clearance in lungs of rats chronically exposed to diesel exhaust. Fundam Appl Toxicol (1987) 1.01
Effect of fatty acids on the proliferation of concanavalin A-stimulated rat lymph node lymphocytes. Int J Biochem (1991) 1.01
Limited PCB antagonism of TCDD-induced malformations in mice. Toxicol Lett (1992) 0.99
Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Chem Res Toxicol (1999) 0.99
Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis (1993) 0.99
Bronchopulmonary lavage cytology in the dog: normal findings. Vet Pathol (1980) 0.99
hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect (1994) 0.99
Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact (2001) 0.98
Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk Anal (1993) 0.98
Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicol Appl Pharmacol (1980) 0.98
The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam Appl Toxicol (1995) 0.98
Effects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human aging. Exp Neurol (2009) 0.97
Toxicokinetics of BDE 47 in female mice: effect of dose, route of exposure, and time. Toxicol Sci (2004) 0.97
Effects of CYP1A2 on disposition of 2,3,7, 8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2',4,4',5,5'-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice. Toxicol Appl Pharmacol (1999) 0.97
A proposed mechanism of benzene toxicity: formation of reactive intermediates from polyphenol metabolites. Toxicol Appl Pharmacol (1981) 0.97
Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis (1994) 0.97
Deposition, retention, and biological fate of inhaled benzo(a)pyrene adsorbed onto ultrafine particles and as a pure aerosol. Toxicol Appl Pharmacol (1982) 0.97
Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam Appl Toxicol (1993) 0.96